Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- B6032 CB-5083Target: p97Summary: p97 inhibitor
- B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell
- A4443 Gliotoxin1 CitationTarget: 20S proteasomal chymotrypsin|Geranylgeranyltransferase I|FarnesyltransferaseSummary: 20S proteasome inhibitor
- A4429 Vialinin ATarget: Deubiquitinating enzymes (DUBs)|IL Receptors|CCL2Summary: USP/isopeptidase T (IsoT)/UCH-L1 DUB inhibitor
- A3966 Doxorubicin3 CitationSummary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic
- A8212 PR-619Target: Deubiquitinating enzymes (DUBs)Summary: Deubiquitylating enzymes (DBUs) inhibitor
- A8250 LY 29400216 CitationTarget: PI3KSummary: Potent PI3K inhibitor
- A2845 OmeprazoleSummary: H+,K+-ATPase inhibitor
- A2324 Dexamethasone (DHAP)Target: interleukin receptorSummary: Glucocorticoidan; anti-inflammatory
- A8323 WP11301 CitationSummary: Deubiquitinase (DUB) inhibitor, Cell permeable